BF Biosciences Limited

BF Biosciences Limited is a joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina and Pakistan’s first biopharmaceutical production facility, designed to USFDA standards.

In 2002, Ferozsons and Bagó entered into commercial partnership to launch the Bagó range of quality branded generics in the field of oncology and hepatology in Pakistan. Within the first two years, together we achieved a leadership position, becoming one of the top 3 companies in both Oncology and hepatology segments.

In FY 2020-21, financial close of state-of-the-art “Line II” expansion comprising of high-speed pre-filled syringes line, 42 square meter lyophilizer, a combi filling line and other ancillary accessories was achieved, which will be operational in FY 2024-25.

We are taking our heritage of trust and credibility to a growing number of international markets, providing life saving drugs in cardiology, hepatology, cancer and other important disease areas.